Exosome-derived circUPF2 enhances resistance to targeted therapy by redeploying ferroptosis sensitivity in hepatocellular carcinoma
Abstract Background Advanced hepatocellular carcinoma (HCC) can be treated with sorafenib, which is the primary choice for targeted therapy. Nevertheless, the effectiveness of sorafenib is greatly restricted due to resistance. Research has shown that exosomes and circular RNAs play a vital role in t...
Kaydedildi:
| Asıl Yazarlar: | , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMC
2024-05-01
|
| Seri Bilgileri: | Journal of Nanobiotechnology |
| Konular: | |
| Online Erişim: | https://doi.org/10.1186/s12951-024-02582-6 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|